Zellimplantation beim idiopathischen Parkinson-Syndrom
Zellimplantation beim idiopathischen Parkinson-Syndrom
A plain-language reading has not been prepared for this paper yet.
Original abstract
Restoration of neuronal cell loss using cell transplantation represents a new strategy to treat neurodegenerative diseases. The replacement of dopaminergic neurons via implantation of embryonic midbrain tissue in patients with Parkinson’s disease has spearheaded this area of research. Animal experiments clearly provided the „proof-of-principle“ to proceed to clinical applications. The first phase 457_psy_10_03_Schwarz 16.10.2003 16:11 Uhr Seite 460 D ie se s D ok um en t w ur de z um p er so nl ic he n G eb ra uc h he ru nt er ge la de n. V er vi el fa lti gu ng n ur m it Z us tim m un g de s V er la ge s.